Equazen Pro

$40.25

Many children with ADHD often have a substantial deficiency of essential fatty acids, as well as a marked omega-3/omega-6 ratio imbalance. These deficiencies are linked to genetic differences in how their bodies metabolize fat. This is important because omega fatty acid deficiencies are thought to negatively affect key brain functions including learning, concentration and mood regulation, as well as inflammatory pathways in the brain.

Equazen® Pro?is a clinically proven medical food that is designed to address differences in omega fatty acid metabolism in many children and adolescents with ADHD and some other related neurodiverse conditions—in the clinically tested, unique ratio of EPA:DHA:GLA.

Quantity:
Add To Cart

Many children with ADHD often have a substantial deficiency of essential fatty acids, as well as a marked omega-3/omega-6 ratio imbalance. These deficiencies are linked to genetic differences in how their bodies metabolize fat. This is important because omega fatty acid deficiencies are thought to negatively affect key brain functions including learning, concentration and mood regulation, as well as inflammatory pathways in the brain.

Equazen® Pro?is a clinically proven medical food that is designed to address differences in omega fatty acid metabolism in many children and adolescents with ADHD and some other related neurodiverse conditions—in the clinically tested, unique ratio of EPA:DHA:GLA.

Many children with ADHD often have a substantial deficiency of essential fatty acids, as well as a marked omega-3/omega-6 ratio imbalance. These deficiencies are linked to genetic differences in how their bodies metabolize fat. This is important because omega fatty acid deficiencies are thought to negatively affect key brain functions including learning, concentration and mood regulation, as well as inflammatory pathways in the brain.

Equazen® Pro?is a clinically proven medical food that is designed to address differences in omega fatty acid metabolism in many children and adolescents with ADHD and some other related neurodiverse conditions—in the clinically tested, unique ratio of EPA:DHA:GLA.